ClinicalTrials.Veeva

Menu

Efficacy of CPAP Therapy on Pulmonary Function Test in Patients With COPD-OSA Overlap Syndrome

M

Mahidol University

Status

Completed

Conditions

COPD
OSA
Lung Function Decreased

Treatments

Other: Control
Device: CPAP therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05857475
MahidolU 4564

Details and patient eligibility

About

To evaluate efficacy of CPAP Therapy on Pulmonary Function Test in Patients With COPD-OSA Overlap Syndrome

Full description

To evaluate efficacy of CPAP Therapy on Pulmonary Function Test in Patients With COPD-OSA Overlap Syndrome by 6 minute walking distance and oxygen consumption.

Enrollment

10 patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis with COPD by GOLD guideline criteria (Post bronchodilator FEV1/FVC < 0.7 or < LLN) with post bronchodilator FEV1 = 30-80%
  • Diagnosis with obstructive sleep apnea with AHI > 15 event/hr. (Moderate OSA or more)
  • Age between 40-80 years
  • Stable disease prior to inclusion.

Exclusion criteria

  • Diagnosis with > 50% of central sleep apnea event
  • History of COPD exacerbation during the past 8 week prior to inclusion.
  • Subjects who cannot perform spirometry test or walking test
  • Subjects with recording history of chronic heart failure, significant arrhythmias, acute myocardial infarction, moderate to severe mitral or aortic valve disease and pulmonary hypertension.
  • Subjects with interstitial lung disease.
  • Subjects with neuromuscular disease.
  • Subjects with morbid obesity (BMI >/=35)
  • Subjects with chronic respiratory infection.
  • Subjects with chronic CO2 retension (PaCO2 >/= 45 from arterial blood gas analysis) or Transcutaneous CO2 during sleep test >/= 45 or Serum bicarbonate level > 27
  • Subjects with acute or active respiratory infecton during 2 week prior to inclusion.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

10 participants in 2 patient groups

CPAP therapy
Experimental group
Description:
CPAP therapy will be used in this arm for 2 month.
Treatment:
Device: CPAP therapy
Control
Other group
Description:
CPAP therapy will not be used in this arm for 2 month. (subject were assign to normal waiting list in order to borrowing hospital PAP machine.)
Treatment:
Other: Control

Trial contacts and locations

1

Loading...

Central trial contact

Pitirat Panpruang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems